Related references
Note: Only part of the references are listed.Injectable and topical neurotoxins in dermatology Indications, adverse events, and controversies
Cerrene N. Giordano et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)
Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology
Marco Pirazzini et al.
PHARMACOLOGICAL REVIEWS (2017)
TAT-BoNT/A(1-448), a novel fusion protein as a therapeutic agent: analysis of transcutaneous delivery and enzyme activity
Parvaneh Saffarian et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2016)
The Uptake of Arginine-Rich Cell-Penetrating Peptides: Putting the Puzzle Together
Roland Brock
BIOCONJUGATE CHEMISTRY (2014)
A survey on Trojan Horse peptides: Opportunities, issues and controlled entry to Troy
Nian-Qiu Shi et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Physicochemical and Biological Characterization of Pep-1/Elastin Complexes
Saman Ahmad Nasrollahi et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2013)
The Receptor Binding Domain of Botulinum Neurotoxin Serotype A (BoNT/A) Inhibits BoNT/A and BoNT/E Intoxications In Vivo
Alon Ben David et al.
CLINICAL AND VACCINE IMMUNOLOGY (2013)
Tryptophan within basic peptide sequences triggers glycosaminoglycan-dependent endocytosis
Cherine Bechara et al.
FASEB JOURNAL (2013)
Cell-penetrating peptides: 20 years later, where do we stand?
Cherine Bechara et al.
FEBS LETTERS (2013)
Botulinum toxins: Mechanisms of action, antinociception and clinical applications
Anthony Wheeler et al.
TOXICOLOGY (2013)
The rat Digit Abduction Score (DAS) assay: A physiological model for assessing botulinum neurotoxin-induced skeletal muscle paralysis
Ron S. Broide et al.
TOXICON (2013)
Surface modification of PLGA nanoparticles via human serum albumin conjugation for controlled delivery of docetaxel
Saeed Manoochehri et al.
DARU-JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Cell-penetrating chitosan/doxorubicin/TAT conjugates for efficient cancer therapy
Jue-Yeon Lee et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Characterization of diffusion and duration of action of a new botulinum toxin type A formulation
Hongran F. Stone et al.
TOXICON (2011)
Treating glabellar lines with botulinum toxin type A-hemagglutinin complex: A review of the science, the clinical data, and patient satisfaction
DeBoulle et al.
Clinical Interventions in Aging (2010)
Cell penetrating peptides: Intracellular pathways and pharmaceutical perspectives
Leena N. Patel et al.
PHARMACEUTICAL RESEARCH (2007)
Aging skin: Causes, treatments, and prevention
Paula E. Bermann
NURSING CLINICS OF NORTH AMERICA (2007)
A non-covalent peptide-based strategy for protein and peptide nucleic acid transduction
Edwige Gros et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2006)
Cell-penetrating peptides: tools for intracellular delivery of therapeutics
S Deshayes et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2005)
Cell-penetrating peptides:: mechanism and kinetics of cargo delivery
M Zorko et al.
ADVANCED DRUG DELIVERY REVIEWS (2005)
A peptide carrier for the delivery of biologically active proteins into mammalian cells
MC Morris et al.
NATURE BIOTECHNOLOGY (2001)
Share Paper
